The in silico pathway analysis was followed by validation of integrin-linked kinase (ILK) along with its associated pathway components, like ITGB1 and VIM, which are known to play important roles in regulating the EMO and EMT transmission responsible for the progression of meningioma. Here, VIM is linked to meningioma.